E. R. H. Walker

504 total citations
17 papers, 387 citations indexed

About

E. R. H. Walker is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, E. R. H. Walker has authored 17 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 7 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in E. R. H. Walker's work include Inflammatory mediators and NSAID effects (5 papers), Plant biochemistry and biosynthesis (5 papers) and Sesquiterpenes and Asteraceae Studies (4 papers). E. R. H. Walker is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Plant biochemistry and biosynthesis (5 papers) and Sesquiterpenes and Asteraceae Studies (4 papers). E. R. H. Walker collaborates with scholars based in United Kingdom, France and United States. E. R. H. Walker's co-authors include R. M. McMillan, Stephen J. Foster, Pierrick Bruneau, Jake MacMillan, Roger W. Jeanloz, Keith H. Gibson, Pierre Sînaÿ, Jean‐Michel Petit, David Waterson and Robert I. Dowell and has published in prestigious journals such as Chemical Society Reviews, Trends in Pharmacological Sciences and British Journal of Pharmacology.

In The Last Decade

E. R. H. Walker

16 papers receiving 358 citations

Peers

E. R. H. Walker

PHARM

PHYSI

Patrice C. Bélanger Canada

H. OBASE Japan

Francis Brion France

Hermann J. Roth Germany

Y. LEBLANC Canada

Norman L. Colbry United States

Ashley Fenwick United Kingdom

D. H. R. Barton United States

Susan Ford United States

Barry Porter United Kingdom

Patrice C. Bélanger Canada

E. R. H. Walker

246 ×1.4

130 ×1.1

61 ×0.7

PHARM

34 ×0.6

PHYSI

50 ×0.9

Citations per year, relative to E. R. H. Walker E. R. H. Walker (= 1×) peers Patrice C. Bélanger

Countries citing papers authored by E. R. H. Walker

Since Specialization

Citations

This map shows the geographic impact of E. R. H. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. R. H. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. R. H. Walker more than expected).

Fields of papers citing papers by E. R. H. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. R. H. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. R. H. Walker. The network helps show where E. R. H. Walker may publish in the future.

Co-authorship network of co-authors of E. R. H. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of E. R. H. Walker. A scholar is included among the top collaborators of E. R. H. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. R. H. Walker. E. R. H. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Walker, E. R. H.. (1995). THE DESIGN OF THERAPEUTICALLY EFFECTIVE 5-LIPOXYGENASE INHIBITORS. European Journal of Medicinal Chemistry. 30. 399s–416s. 3 indexed citations

Bird, T. G. C., Pierrick Bruneau, Robert I. Dowell, et al.. (1993). Structure and activity relationships leading to the discovery of ICI D2138, a selective, potent and orally active inhibitor of 5-lipoxygenase.. PubMed. 6(1-3). 249–57. 6 indexed citations

McMillan, R. M., et al.. (1992). Pre‐clinical pharmacology of ICI D2138, a potent orally‐active non‐redox inhibitor of 5‐lipoxygenase. British Journal of Pharmacology. 107(4). 1042–1047. 34 indexed citations

McMillan, R. M. & E. R. H. Walker. (1992). Designing therapeutically effective 5-lipoxygenase inhibitors. Trends in Pharmacological Sciences. 13(8). 323–330. 116 indexed citations

Dowell, Robert I., Philip N. Edwards, Stephen J. Foster, et al.. (1992). ChemInform Abstract: Methoxytetrahydropyrans. A New Series of Selective and Orally Potent 5‐ Lipoxygenase Inhibitors.. ChemInform. 23(51). 7 indexed citations

Foster, Stephen J., Pierrick Bruneau, E. R. H. Walker, & R. M. McMillan. (1990). 2‐Substituted indazolinones: orally active and selective 5‐lipoxygenase inhibitors with anti‐inflammatory activity. British Journal of Pharmacology. 99(1). 113–118. 38 indexed citations

Walker, E. R. H., et al.. (1982). A new general method of α-amino-alkylation. Tetrahedron Letters. 23(40). 4123–4126. 22 indexed citations

Walker, E. R. H.. (1976). The functional group selectivity of complex hydride reducing agents. Chemical Society Reviews. 5. 23–23. 121 indexed citations

Gibson, Keith H., et al.. (1976). Synthesis and biological activity of 16,17-configurationally-rigid-17-aryl 18,19,20-trinorprostaglandins. Prostaglandins. 12(4). 493–500. 3 indexed citations

10.

Walker, E. R. H., et al.. (1975). The Acetoxyfulvene Synthesis of Prostaglandins: A New, Versatile Synthesis of dl-PGF_1δ, dl-PGF_2α, dl-PGE₁ and dl-PGE₂ from a Common Intermediate. Synthetic Communications. 5(3). 221–226. 5 indexed citations

11.

MacMillan, Jake & E. R. H. Walker. (1972). Terpenoids. Part V. Rearrangement of ent-kaurane 15β,16β-epoxide to ent-(16R)-atisan-15-one. Journal of the Chemical Society Perkin Transactions 1. 1274–1277. 3 indexed citations

12.

MacMillan, Jake & E. R. H. Walker. (1972). Terpenoids. Part III. The enolisation–ketonisation and optical rotatory dispersion of the ent-kauran-15-ones and 13β-kauran-15-ones. Journal of the Chemical Society Perkin Transactions 1. 986–990. 12 indexed citations

13.

Petit, Jean‐Michel, et al.. (1972). Synthèse du 2-amino-3-O-(L-1-carboxyéthyl)-2-désoxy-D-glucose(acide isomuramique) et de ses dérivés. Carbohydrate Research. 24(2). 415–425. 7 indexed citations

14.

MacMillan, Jake & E. R. H. Walker. (1972). Terpenoids. Part II. Some ringDderivatives of 13β-kaurane. Journal of the Chemical Society Perkin Transactions 1. 981–985. 5 indexed citations

15.

MacMillan, Jake & E. R. H. Walker. (1972). Terpenoids. Part IV. The nuclear magnetic resonance properties of the stereoisomeric ent-kauran-15-ols and 13β-kauran-15-ols. Journal of the Chemical Society Perkin Transactions 1. 1272–1274.

16.

MacMillan, Jake & E. R. H. Walker. (1969). The nuclear magnetic resonance and stereochemistry of 9,10-derivatives of 9,10-dihydroanthracene. Journal of the Chemical Society D Chemical Communications. 1031–1031. 1 indexed citations

17.

Jeanloz, Roger W. & E. R. H. Walker. (1967). Muramic acid having a reduced side-chain: 2-amino-2-deoxy-3-O-[(S)-1-(hydroxymethyl)ethyl]-D-glucose. Carbohydrate Research. 4(6). 504–506. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact